v3.26.1
Equity (Tables)
6 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Movement of Warrant

For the six months ended March 31, 2026, the movement of warrants is as follows:

 

    For the six months ended March 31, 2026  
   

Total

Valuation

    Issuance  
    US$     Share     Valuation     Average
exercise
price
 
Balance at beginning of the period   $ 494,048       5,708     $ 494,048     $ 87  
Issuance                        
Change in fair value of warrant liability     (128,286 )     5,708       (128,286 )     22  
Exercise                        
Balance at end of the period   $ 365,762       5,708     $ 365,762     $ 64  

 

For the six months ended March 31, 2025, the movement of warrants is as follows:

 

    For the six months ended March 31, 2025  
    Total
Valuation
    Issuance  
    US$     Share     Valuation     Average
exercise
price
 
Balance at beginning of the period   $           $     $  
Issuance(a)     14,493,455       396,040       14,493,455       37  
Change in fair value of warrant liability     (3,734,131 )           (3,734,131 )      
Exercise     9,909,270       364,750       9,909,270       27  
Balance at end of the period   $ 850,054       31,290     $ 850,054     $ 27  
Schedule of Binominal Tree Pricing Model

The fair value of warrants aforementioned was determined using the Binominal Tree pricing model and the following assumptions: 

 

    March 31,     September 30,     September 22,     April 29,     February 17,     October 31,  
    2026     2025     2025     2025     2025     2024  
Share price   $ 75     $ 97.5     $ 104.63     $ 123     $ 227     $ 321.75  
Share price (Pre-splits)     1.5       1.95       2.09       2.46       4.49       0.43  
Exercise price     75.75       75.75       75.75       75.75       75.75       75.75  
Exercise price (Pre-splits)     1.515       1.515       1.515       1.515       1.515       0.101  
Expected dividend yield     -       -       -       -       -       -  
Risk free interest rate     3.85 %     3.68 %     3.65 %     3.74 %     4.32 %     4.15 %
Expected life     3.6       4.1       4.1       4.5       4.7       5  
Expected volatility     88.6 %     100.3 %     94.7 %     102.9 %     103.2 %     100.5 %
Schedule of stock-based compensation expenses

The stock-based compensation expenses incurred by the Company for the six months ended March 31, 2026 and 2025 are as follows:

 

   

For the Six Months Ended

March 31,

 
    2026     2025  
    (Unaudited)     (Unaudited)  
Research and development expenses   $ 8,667,172       1,419,000  
General and administrative expenses     4,090,761        
Selling and marketing expenses     708,687        
Total stock-based compensation   $ 13,466,620     $ 1,419,000